Human parainfluenza virus type 3 infections in a haemato-oncology unit: social distancing measures needed in outpatient clinics
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Journal of Hospital Infection
- Vol. 116, 60-68
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Human Parainfluenza Virus Infection after Hematopoietic Stem Cell Transplantation: Risk Factors, Management, Mortality, and Changes over TimeTransplantation and Cellular Therapy, 2012
- Nosocomial transmission of parainfluenza 3 virus in hematological patients characterized by molecular epidemiologyTransplant Infectious Disease, 2011
- Incubation periods of acute respiratory viral infections: a systematic reviewThe Lancet Infectious Diseases, 2009
- Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infectionBlood, 2007
- Parainfluenza VirusesClinical Microbiology Reviews, 2003
- Parainfluenza Virus 3 Infection after Stem Cell Transplant: Relevance to Outcome of Rapid Diagnosis and Ribavirin TreatmentClinical Infectious Diseases, 2001
- Respiratory Disease Due to Parainfluenza Virus in Adult Bone Marrow Transplant RecipientsClinical Infectious Diseases, 1996
- A Live Human Parainfluenza Type 3 Virus Vaccine Is Attenuated and Immunogenic in Healthy Infants and ChildrenThe Journal of Infectious Diseases, 1995
- Parainfluenza virus infection in adult bone marrow transplant recipientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- Survival and disinfection of parainfluenza viruses on environmental surfacesAmerican Journal of Infection Control, 1990